Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
about
Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcomaHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerVEGFR-2 expression in human melanoma: revised assessment.High-resolution ultrasound imaging of cutaneous lesions.Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatmentPrognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up periodIncreased laser Doppler flow in skin tumors corresponds to elevated vessel density and reactive hyperemia.Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis.Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.S100A13 is a new angiogenic marker in human melanomaPotential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancerAction of Lovastatin (Mevinolin) on an in vitro model of angiogenesis and its co-culture with malignant melanoma cell linesExpression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.Molecular pathogenesis and prognostic factors in endometrial carcinoma.Angiogenesis, lymphangiogenesis, and melanoma metastasis.Remodeling of the microenvironment by aggressive melanoma tumor cells.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomaVascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.Molecular profiling of angiogenesis markers.Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteinsGlomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer.Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculatureTissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo.Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapiesMechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications.Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.Effects of bisphenol A and 17β-estradiol on vascular endothelial growth factor A and its receptor expression in the non-cancer and cancer ovarian cell lines.Role of thrombospondin 1 in liver diseases.Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.The role of VEGF in melanoma progression.Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanism.
P2860
Q21260421-2765AE85-5D3C-4A1F-BA13-89A3EF6EFDB1Q24798737-87F5F031-8C04-43DD-9610-BC199E3D187DQ30423356-11CE639B-5226-4DD0-A4E4-F780D8FDF622Q30445841-71345643-B033-4D0B-99FD-532965D1C5BCQ30475154-904A1581-EE3F-4F47-BFA6-951A24BE9C35Q30499036-213B54C5-3E85-446A-9B5E-02490237BDA7Q33231917-E834CD82-B50E-491B-A7CF-01AD8A794AB6Q33355483-3D9097B9-E6B7-43BE-BF9C-F19001B7D051Q33390467-8C07E7D1-076E-4567-A4EF-9C7019BD66F6Q33557480-6D34669A-64E9-45AD-A84A-F3DB9321E9FFQ33665758-E37FD03A-3CB2-4C5E-8A54-650B76542420Q33687242-5695D16A-F737-4219-84A4-79EEC4480705Q33899574-0DC97070-20CB-4E77-B9B9-7431590F393DQ34128953-2DF0E822-F052-40EC-97B2-AFBD34C66179Q34538284-97FB13D0-7D88-42CA-B28D-F3058F7E09ADQ34678882-D0C25D6F-69AE-436C-9225-E16DBC9B0C0DQ34997320-36A0D884-A32C-49C9-AF44-A69F91DB285EQ35065032-E4EADE2F-D19A-4113-BE45-8D5FDAD905F5Q35146591-829CD981-AE60-43C7-A794-1FE970741123Q35157766-164B722D-B63E-4D73-9341-5F8CAB1E9CA9Q35234354-86A1B42D-C2A9-49BB-A9A0-A29E69965BB6Q35289963-8C734350-10FC-4959-BA3D-8C28315C88ACQ35747435-05F2DB3F-9017-4075-9DE0-82E6ED71DDBCQ36014062-9F0AA74E-4D37-49E8-BD72-0C0FF0296592Q36346020-6A989207-842E-453A-A6CB-9FEABC37FED2Q36447447-F979B79C-C611-4550-98C2-8A74AA6EDEE8Q36648435-D0FB74BE-31AC-4D7F-A642-9277D0640538Q37020248-51D46D9E-C328-4E4A-BAFD-1469F77BCE45Q37288883-AC1273E6-CE78-4432-A52C-EC3AC29529E7Q37337431-48C4A25F-D4D3-4F73-B99C-63FDD92CAD48Q37385797-02A1591F-CB45-4AEE-B9ED-6A3147164D13Q38196881-3C7C016D-6F1D-4200-A19D-D7F05A505D5CQ38429857-10F276A0-BCA3-436E-9340-CAB4B82B24CCQ38431670-284EAE0F-C3AD-4DC8-886F-F7974F102855Q38873842-B5518B5F-FDB2-4C82-B4B2-F31CD4B04224Q38918913-D13B8F31-2E2F-4D98-B778-A5A7AE2C3FEDQ39850353-942B00DA-11BB-4875-B3AD-372ED7313A12Q40038149-A8F3C521-3FB6-4610-9B43-C691C5735908Q40117553-FE0958B4-31E4-4607-8F93-7330B95CCF24Q40655691-C010EEDF-E462-4BED-8A5D-0470E3DE1A70
P2860
Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Expresson of vascular endothel ...... rtical growth phase melanomas.
@ast
Expresson of vascular endothel ...... rtical growth phase melanomas.
@en
type
label
Expresson of vascular endothel ...... rtical growth phase melanomas.
@ast
Expresson of vascular endothel ...... rtical growth phase melanomas.
@en
prefLabel
Expresson of vascular endothel ...... rtical growth phase melanomas.
@ast
Expresson of vascular endothel ...... rtical growth phase melanomas.
@en
P2860
P1476
Expresson of vascular endothel ...... rtical growth phase melanomas.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)61688-4
P407
P577
2001-07-01T00:00:00Z